Prime Radiant Partners Invests $50 Million in Cellares Ahead of Potential 2027 IPO
2026-06-15 12:22:13
Prime Radiant Partners is investing $50 million in Cellares as the biotechnology company raises money ahead of a potential initial public offering in 2027. In the deal, according to Bloomberg, Cellares is developing high-tech robots designed to mass-produce cancer treatments.
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
